Today in History for July 2: In 311, Miltiades was elected the 32nd pope of the Catholic Church. During his pontificate, Christianity was finally tolerated by Rome, following the Emperor Constantine's ...

Adding targeted radiation to chemotherapy prior to surgery may offer better control of pancreatic tumors—potentially reducing ...

During therapy, some cancer cells evolve to escape elimination. Newer anticancer drugs that can overcome this resistance are necessary. Now, researchers from Japan demonstrate that aromatic ...

Regeneron Pharmaceuticals has won FDA accelerated approval of its Lynozyfic treatment for certain patients with the blood ...

Patients with ovarian clear cell carcinoma (OCCC) whose tumors have specific mutations in the PPP2R1A gene were found to have ...

ImmunityBio, Inc. (NASDAQ:IBRX) ranks among the 30 stocks expected to beat the market by 20 percentage points this year. With a price target of $8, H.C. Wainwright analysts reiterated their Buy rating ...

In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.